Intelligence · Clinical Development
Pipeline search results
Programs matching “eli lilly” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 169 pipeline programs matching "eli lilly" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
J2J-OX-JZLC
Eli Lilly Co.
Breast Cancer
1 trial -
J2S-MC-GZME
Eli Lilly Co.
Alcohol Use Disorder
1 trial -
J2T-MC-KGBT
Eli Lilly Co.
Perennial Allergic Rhinitis (PAR)
1 trial -
J2T-MC-KGBU
Eli Lilly Co.
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
1 trial -
J3M-MC-JZQB
Eli Lilly Co.
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cancer
1 trial -
J3M-MC-JZQH
Eli Lilly Co.
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
1 trial -
J3R-MC-YDAF
Eli Lilly Co.
Obesity, Overweight
1 trial -
J3R-MC-YDAG
Eli Lilly Co.
Obesity, Overweight
1 trial -
J3R-MC-YDAL
Eli Lilly Co.
Overweight, Obesity
1 trial -
J3R-MC-YDAO
Eli Lilly Co.
Overweight, Obesity, Sleep Apnea, Obstructive
1 trial -
J4G-MC-JZVD
Eli Lilly Co.
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
1 trial -
J5E-MC-JZXB
Eli Lilly Co.
Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Neoplasm Metastasis
1 trial -
J6M-MC-JSGD
Eli Lilly Co.
Neoplasm Metastasis, Breast Neoplasms
1 trial -
LY2127399
Eli Lilly and Company
Rheumatoid Arthritis
1 trial -
LY2127399
Eli Lilly and Company
Systemic Lupus Erythematosus
1 trial -
LY2216684
Eli Lilly and Company
Major Depressive Disorder
1 trial -
Lebrikizumab
Eli Lilly and Company
Atopic Dermatitis
1 trial -
METFORMIN , DAPAGLIFLOZIN
Eli Lilly Co.
Type 2 Diabetes
1 trial -
Mirikizumab
Eli Lilly and Company
Ulcerative Colitis
2 trials -
Mirikizumab SC
Eli Lilly and Company
Ulcerative Colitis
1 trial -
Mirikizumab, Mirikizumab
Eli Lilly Co.
Ulcerative Colitis
1 trial -
N1T-MC-MALO
Eli Lilly Co.
Metabolic Dysfunction-Associated Steatotic Liver Disease
1 trial -
Necitumumab
Eli Lilly and Company
Non Small Cell Lung Cancer
1 trial -
Orforglipron
Eli Lilly and Company
Type 2 Diabetes
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.